Bayer Yakuhin, a subsidiary of Bayer HealthCare, has entered into an agreement to distribute Femasys' FemVue saline-air device in Japan.

FemVue saline-air device facilitates physicians to assess woman’s fertility by passing ultrasound into fallopian tubes.

Femasys president and CEO Kathy Lee-Sepsick said the company’s partnership with Bayer now provides physicians in Japan access to its FemVue saline-air device for fallopian tube assessment as a first step in infertility diagnosis or as a part of fertility confirmation.

FemVue saline-air device is also available in Europe, Canada and is distributed in the US by Norgenix.